Investor Relations

Investor Overview

KemPharm uses its LAT platform technology to discover and develop prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety.


Stock Quote
KMPH (Common Stock)
PriceChange% ChangeVolume
$4.25 + 0.051.19%17,651
Previous CloseToday's OpenIntraday HighIntraday Low
Exchange: NASDAQ (US Dollar)
05/26/17 4:00 p.m. ET
Refresh quote
Recent NewsMore >>
KemPharm, Inc. Reports First Quarter 2017 Results
KemPharm, Inc. to Report First Quarter 2017 Results
KemPharm to Present at the 2nd Annual Neuroscience Biopartnering and Investment Forum
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources